Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • M&A

Eleusis And Silver Spike Acquisition Corp. II Mutually Agree To Terminate Business Combination Agreement

By Bill Haddad
Today, 5:12 AM
Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II (“Silver Spike II” or “SPKB”) (NASDAQ:SPKB), a

SPKB

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics
  • Small Cap

From Finance To Psychology, Shlomi Raz, CEO Of Eleusis: Meet Our Speakers

By Fermin Orgambide
Today, 5:12 AM
CEO and founder of psychedelics company Eleusis, Shlomi Raz has extensive experience in managing companies.

ELEU

Read More
2 minute read
  • FDA
  • Legal
  • News

Eleusis Announces Notice Of Allowance For U.S. Patent Application With Claims Covering Lead Drug Candidate ELE-Psilo

By Benzinga Newsdesk
Today, 5:12 AM
Eleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and Trademark Office. This salt form and formulations are

SPKB

Read More
4 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri

By Natan Ponieman
Today, 5:12 AM
Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychedelics legislation continues to sweep across the country.

CMPS

Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Small Cap

Psychedelics Firm Eleusis Goes Public Via Merger With Silver Spike Acquisition Creating $450M Company

By Nina Zdinjak
Today, 5:12 AM
British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“SPKB”) (NASDAQ: SPKB), a special purpose acquisition company sponsored by an affiliate of Silver Spike Capital.

SPKB

Read More
1 minute read
  • News

‘British Psychedelic-Drug Firm Eleusis Plans $450 Million SPAC Deal’ – Bloomberg

By Benzinga Newsdesk
Today, 5:12 AM
https://www.bloomberg.com/news/articles/2022-01-20/psychedelics-firm-eleusis-said-to-merge-with-silver-spike-spac?utm_source=google&utm_medium=bd&cmpId=google&sref=V7uxlNge

SPKB

Read More
2 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Interview
  • Markets
  • News
  • Small Cap

Why Does CNBC’s Tim Seymour Think It’s Wise To Invest In Cannabis?

By Jelena Martinovic
Today, 5:12 AM
With a spike in share prices within the cannabis sector in the week following the Republicans' release of their

CNBS

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service